| scholarly article | Q13442814 |
| P50 | author | Ji Hyae Lim | Q53484009 |
| P2093 | author name string | So Yeon Park | |
| Hyun Mee Ryu | |||
| P2860 | cites work | ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities | Q22242787 |
| Amniocentesis and chorionic villus sampling for prenatal diagnosis | Q24247990 | ||
| Bisulfite genomic sequencing: systematic investigation of critical experimental parameters | Q24555629 | ||
| A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands | Q24562877 | ||
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis | Q24651226 | ||
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| Comparative isoschizomer profiling of cytosine methylation: the HELP assay | Q24685607 | ||
| Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells | Q29618090 | ||
| Role for DNA methylation in genomic imprinting | Q29618669 | ||
| DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study | Q30414408 | ||
| Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. | Q30704921 | ||
| Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
| Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. | Q54574187 | ||
| Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. | Q54770850 | ||
| Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients | Q57240090 | ||
| Systematic Search for Placental DNA-Methylation Markers on Chromosome 21: Toward a Maternal Plasma-Based Epigenetic Test for Fetal Trisomy 21 | Q58029321 | ||
| Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population | Q58416056 | ||
| A DNA methylation imprint, determined by the sex of the parent, distinguishes the Angelman and Prader-Willi syndromes | Q68019576 | ||
| Prenatal DNA diagnosis of a single-gene disorder from maternal plasma | Q73074402 | ||
| Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma | Q73141494 | ||
| Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma | Q77372981 | ||
| Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation | Q77678904 | ||
| Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients | Q77804773 | ||
| Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction | Q78175404 | ||
| ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy | Q80138010 | ||
| Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting | Q83395075 | ||
| Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome | Q33595266 | ||
| Epigenetics in the placenta | Q33620204 | ||
| Methylated DNA immunoprecipitation and microarray-based analysis: detection of DNA methylation in breast cancer cell lines | Q33754737 | ||
| Sensitive digital quantification of DNA methylation in clinical samples | Q33761814 | ||
| Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker | Q33797671 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma | Q34087801 | ||
| Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities | Q34149751 | ||
| Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. | Q34168875 | ||
| Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience | Q34192088 | ||
| Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
| Fetal DNA in maternal plasma: the plot thickens and the placental barrier thins | Q34385179 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
| Effect of site-specific modification on restriction endonucleases and DNA modification methyltransferases | Q34871498 | ||
| The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome | Q34994416 | ||
| Microchimerism in endocrine pathology | Q35694186 | ||
| Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities | Q35856339 | ||
| Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
| Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy | Q36406163 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Non-invasive prenatal diagnosis by single molecule counting technologies | Q37525261 | ||
| DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight | Q39853397 | ||
| Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. | Q39904859 | ||
| Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. | Q40028555 | ||
| Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study | Q44552941 | ||
| Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood | Q44645735 | ||
| Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood | Q46167117 | ||
| First-trimester or second-trimester screening, or both, for Down's syndrome | Q46799629 | ||
| Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report | Q48004844 | ||
| Tissue-specific differences in DNA methylation in various mammals | Q48793834 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 58-66 | |
| P577 | publication date | 2013-03-12 | |
| P1433 | published in | Obstetrics & gynecology science | Q26853987 |
| P1476 | title | Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood | |
| P478 | volume | 56 |
| Q40201029 | A Pilot Study of Noninvasive Prenatal Diagnosis of Alpha- and Beta-Thalassemia with Target Capture Sequencing of Cell-Free Fetal DNA in Maternal Blood |
| Q41542227 | Combined detection of α-fetoprotein and free β-human chorionic gonadotropin in screening for trisomy 21 and management of cases in the moderate risk value range |
| Q35084533 | Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21 |
| Q50052174 | Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma |
| Q41496938 | MeDIP Real-Time qPCR has the Potential for Noninvasive Prenatal Screening of Fetal Trisomy 21. |
Search more.